← Leaderboards
Calogera Maria Simonaro
Icahn School Of Medicine At Mount Sinai
$2,346,991
Attributed
$2,346,991
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $602.9K · FY2009–14$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$2,346,991 · 2
By mechanism
R01$1,880,866 · 1
R21$466,125 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Melissa Pittel Wasserstein$13,874,586
- James C Iatridis$19,034,759
Others in their field
Top investigators on “Mucopolysaccharidosis Vi”
- Mark E Haskins · University Of Pennsylvania$7,419,296
- Melissa Pittel Wasserstein · Icahn School Of Medicine At Mount Sinai$3,191,610
- Chester B Whitley · University Of Minnesota Twin Cities$2,842,625
- Lynda Elizabeth Polgreen · University Of Minnesota$877,781
- Carole L. Cramer · Biodefense Technologies, Inc.$758,333
- David Radin · Biostrategies, Lc$758,333
Research focus
Mucopolysaccharidosis ViWestern BlottingInflammationMucopolysaccharidosesRattusUrineDisease ProgressionEnzymesInflammatoryMonitorPharmaceutical PreparationsAnti-Inflammatory AgentsCartilageStagingCell ProliferationChondrocytesAnimal ModelEnzyme Replacement TherapyBaseAnimalsInheritedBoneAnti-InflammatoryApoptosis Inhibitor
Grant awards (7)
Novel Oral Therapy For the Mucopolysaccharidoses$211,875
R21 · FY2014 · DK · contact PI
Novel Therapies and Biomarkers for the Mucopolysaccharidoses$348,680
R01 · FY2013 · DK · contact PI
Novel Oral Therapy For the Mucopolysaccharidoses$254,250
R21 · FY2013 · DK · contact PI
Novel Therapies and Biomarkers for the Mucopolysaccharidoses$361,327
R01 · FY2012 · DK · contact PI
Novel Therapies and Biomarkers for the Mucopolysaccharidoses$361,327
R01 · FY2011 · DK · contact PI
Novel Therapies and Biomarkers for the Mucopolysaccharidoses$402,732
R01 · FY2010 · DK · contact PI
Novel Therapies and Biomarkers for the Mucopolysaccharidoses$406,800
R01 · FY2009 · DK · contact PI